Clinical trial
Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With…
NCT00002003 · Lederle Laboratories, Industry · Completed
Key facts
| NCT number | NCT00002003 |
|---|---|
| Title | Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas |
| Official title | Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas |
| Lead sponsor | Lederle Laboratories, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Non-Hodgkin, HIV Infections |
| Intervention type | Drug |
| Interventions | Mitoxantrone hydrochloride, Etoposide |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: